Use of Retained Earnings for Business Expansion, Research and Development, and Production Facilities
First written in FY2016. 19 of 32 entries say "Advanced", first in FY2017-Q1. Latest entry: 2026-05-15.
21 other companies' latest entry also says "Advanced".
- 2026-05-15AdvancedEarnings
「We intend to use these funds to expand our business fields, strengthen our research and development structure, and expand our production facilities, among other purposes.」
Reaffirms the policy of using funds for business expansion, research and development, and production facilities. - FY2026-H1AdvancedAnnual report
「The Group's research and development expenditure during the current interim consolidated fiscal period was ¥514 million.」
The company recorded research and development expenditure of ¥514 million. In addition, it spent ¥2.208 billion on the acquisition of property, plant and equipment, continuing to use funds for research and development and production facilities. - FY2025AdvancedAnnual report
「The Group intends to use funds to respond to various changes in the operating environment expected in the future and to achieve further development and growth, including expanding its business fields, strengthening its research and development capabilities, enhancing production facilities, and making growth investments in human capital.」
The company continues to identify its business fields, research and development, production facilities, and human capital as uses of internal funds and other sources, and during the fiscal year recorded research and development expenditure of ¥1.033 billion and capital expenditures of ¥3.075 billion. - FY2025-H1AdvancedAnnual report
「Cash used in investing activities was ¥2.397 billion (compared with ¥2.172 billion used in the same period of the previous year). This was mainly attributable to ¥567 million in expenditure for placing funds in time deposits and ¥1.604 billion in expenditure for the acquisition of property, plant and equipment.」
During the current interim consolidated fiscal period, the company spent ¥1.604 billion on the acquisition of property, plant and equipment and continued to make growth investments in its business base, production facilities and other areas. - FY2024AdvancedAnnual report
「Total R&D expenses for the consolidated fiscal year were ¥954 million.」
The company recorded research and development expenditure of ¥954 million and made capital expenditures of ¥3.877 billion, as well as spending ¥565 million to acquire 丸二株式会社, thereby using funds for research and development, production facilities and business expansion. - FY2024-Q3AdvancedAnnual report
「Cash used in investing activities was ¥3.55 billion (compared with ¥852 million used in the same quarter of the previous year). This was mainly attributable to ¥2.955 billion in expenditure for the acquisition of property, plant and equipment and ¥435 million in expenditure for the acquisition of shares in subsidiaries resulting in a change in the scope of consolidation.」
During the third quarter of the cumulative period, the company spent ¥2.955 billion on the acquisition of property, plant and equipment and ¥435 million on the acquisition of shares in subsidiaries, including 丸二株式会社. It also allocated ¥698 million to research and development, demonstrating continued use of funds for facilities, business expansion and research and development. - FY2024-Q2AdvancedAnnual report
「Consideration for the acquisition Cash ¥565 million Acquisition cost ¥565 million」
The company paid ¥565 million in cash for the consideration related to making 丸二株式会社 a subsidiary, using internal funds to strengthen its manufacturing capabilities and production system. - FY2024-Q1AdvancedAnnual report
「Funding and method of payment The consideration for the acquisition is scheduled to be paid in cash from funds on hand within the Group.」
The company plans to pay the consideration for making 丸二株式会社 a subsidiary using cash on hand within the Group, providing a specific example of using internal funds to strengthen its manufacturing capabilities and production system. The planned number of shares to be acquired is 20,000, and the planned voting rights ratio after the acquisition is 100%. - FY2023AdvancedAnnual report
「The Group intends to use funds to respond to various changes in the operating environment expected in the future and to achieve further development and growth, including expanding its business fields, strengthening its research and development capabilities, enhancing production facilities, and making growth investments in human capital.」
The company added growth investment in human capital to the uses of funds including retained earnings, and during the fiscal year recorded research and development expenditure of ¥934 million and capital expenditures of ¥1.277 billion. - FY2023-Q3AdvancedAnnual report
「Cash used in investing activities was ¥852 million (compared with ¥1.24 billion used in the same quarter of the previous year). This was mainly attributable to ¥907 million in expenditure for the acquisition of property, plant and equipment.」
The company continued to invest in its production, logistics and other business infrastructure, spending ¥907 million on the acquisition of property, plant and equipment during the third quarter of the cumulative period. - FY2023-Q2AdvancedAnnual report
「This was mainly due to ¥612 million in expenditures for the acquisition of property, plant and equipment.」
The company spent ¥612 million on the acquisition of property, plant and equipment and continues to use funds for its business base, production facilities and other purposes. - FY2023-Q1AdvancedAnnual report
「(4) Planned investment amount: THB 700,000,000 (approximately ¥2.6 billion) (5) Funding plan: To be funded with internal funds.」
The company decided to invest approximately ¥2.6 billion in a new plant in Thailand using internal funds, including retained earnings. This is a specific example of using internal funds to establish an overseas manufacturing base. - FY2022AdvancedAnnual report
「The Group intends to use funds to respond to various changes in the operating environment expected in the future and to achieve further development and growth, including expanding its business fields, strengthening its research and development capabilities, and enhancing production facilities.」
During the fiscal year, the company recorded research and development expenditure of ¥957 million and capital expenditures of ¥1.452 billion. It also invested in スギショーテクニカルフーズ and made ヤマキン a subsidiary, using retained earnings for its business, research and development, and production capabilities. - FY2022-Q2RestatedAnnual report
「The Group's research and development expenditure during the second quarter of the current consolidated cumulative period was ¥493 million. There was no material change in the status of the Group's research and development activities during the period.」
The company recorded research and development expenditure of ¥493 million, stating that there was no material change in its research and development activities. - FY2021AdvancedAnnual report
「Total R&D expenses for the consolidated fiscal year were ¥832 million.」
The company recorded research and development expenditure of ¥832 million and capital expenditures of ¥1.164 billion, mainly for production facilities, and is proceeding with the use of funds for research and development and facility expansion. - FY2021-Q3RestatedAnnual report
「The Group's research and development expenditure during the third quarter of the current consolidated cumulative period was ¥592 million. There was no material change in the status of the Group's research and development activities during the period.」
The company continued its research and development activities and reported expenditure of ¥592 million for the third quarter of the cumulative period. It stated that there was no material change in the status of its activities. - FY2021-Q2RestatedAnnual report
「The Group's research and development expenditure during the second quarter of the current consolidated cumulative period was ¥400 million. There was no material change in the status of the Group's research and development activities during the period.」
The company continued its research and development activities and reported expenditure of ¥400 million for the second quarter of the current consolidated cumulative period. It stated that there was no material change in the status of its activities. - FY2020AdvancedAnnual report
「Total research and development expenditure for the current consolidated fiscal year was ¥546 million.」
The company recorded research and development expenditure of ¥546 million and implemented its policy of using retained earnings to strengthen its research and development capabilities. It also made capital expenditures of ¥718 million. - FY2020-Q2RestatedAnnual report
「The Group's research and development expenditure during the second quarter of the current consolidated cumulative period was ¥274 million. There was no material change in the status of the Group's research and development activities during the period.」
The company recorded research and development expenditure of ¥274 million, stating that there was no material change in the status of its research and development activities. - FY2019AdvancedAnnual report
「Total research and development expenditure for the current consolidated fiscal year was ¥555 million.」
The company recorded research and development expenditure of ¥555 million, demonstrating the implementation of its policy of using retained earnings to strengthen its research and development capabilities. - FY2019-Q3RestatedAnnual report
「The Group's research and development expenditure during the third quarter of the current consolidated cumulative period was ¥417 million. There was no material change in the status of the Group's research and development activities during the period.」
The company recorded cumulative research and development expenditure of ¥417 million, stating that there was no material change in the status of its research and development activities. - FY2019-Q2RestatedAnnual report
「The Group's research and development expenditure during the second quarter of the current consolidated cumulative period was ¥278 million. There was no material change in the status of the Group's research and development activities during the period.」
The company recorded cumulative research and development expenditure of ¥278 million, stating that there was no material change in the status of its research and development activities. - FY2019-Q1RestatedAnnual report
「The Group's research and development expenditure during the first quarter of the current consolidated cumulative period was ¥134 million. There was no material change in the status of the Group's research and development activities during the period.」
The company recorded research and development expenditure of ¥134 million and explained that there was no material change in its research and development activities. - FY2018AdvancedAnnual report
「The Group made total capital expenditures of ¥1.841 billion during the current consolidated fiscal year, mainly for the construction of new logistics facilities.」
The company invested ¥1.841 billion, mainly in logistics facilities and equipment, and used retained earnings for business expansion, the enhancement of production facilities and other purposes. Research and development expenditure totaled ¥569 million. - FY2018-Q3RestatedAnnual report
「The Group's research and development expenditure during the third quarter of the current consolidated cumulative period was ¥431 million. There was no material change in the status of the Group's research and development activities during the period.」
The company continued its research and development expenditure and reported cumulative expenditure of ¥431 million, stating that there was no material change in the status of its activities. - FY2018-Q2RestatedAnnual report
「The Group's research and development expenditure during the second quarter of the current consolidated cumulative period was ¥292 million. There was no material change in the status of the Group's research and development activities during the period.」
The company continued its research and development expenditure and reported ¥292 million for the second quarter of the current consolidated cumulative period. There was no material change in the status of its activities. - FY2018-Q1RestatedAnnual report
「Group-wide research and development expenditure during the first-quarter consolidated cumulative period was ¥150 million. There were no material changes in the status of our group’s R&D activities during the period.」
The company continued to incur research and development expenditure and reported cumulative expenditure of ¥150 million for the period. It stated that there was no material change in its research and development activities. - FY2017AdvancedAnnual report
「To improve production efficiency and strengthen sales capabilities, the Group made total capital expenditures of ¥1.62 billion during the current consolidated fiscal year, mainly for the expansion of production facilities.」
The company invested ¥1.62 billion, mainly in production facilities, and research and development expenditure totaled ¥618 million. It reported the implementation of its policy of using retained earnings for growth investment. - FY2017-Q3RestatedAnnual report
「The Group's research and development expenditure during the third quarter of the current consolidated cumulative period was ¥470 million. There was no material change in the status of the Group's research and development activities during the period.」
The company reported continued research and development expenditure together with the cumulative amount, stating that there was no material change in the status of its activities. - FY2017-Q2RestatedAnnual report
「The Group's research and development expenditure during the second quarter of the current consolidated cumulative period was ¥315 million.」
The company continued to incur research and development expenditure and reported cumulative expenditure of ¥315 million for the quarter. - FY2017-Q1AdvancedAnnual report
「The Group's research and development expenditure during the first quarter of the current consolidated cumulative period was ¥163 million. This was mainly attributable to ¥1.05 billion in expenditure for the acquisition of property, plant and equipment and other items.」
The company recorded specific expenditures on research and development and property, plant and equipment during the quarter, demonstrating the implementation of its policy of using retained earnings for growth investment. - FY2016First statedAnnual report
「The company intends to use retained earnings flexibly and effectively to respond to various changes in the operating environment expected in the future and to achieve further development and growth, including expanding its business fields, strengthening its research and development capabilities, and enhancing production facilities.」
The company has indicated a policy of allocating retained earnings to growth investment in its business fields, research and development, and production facilities.